SciClone sets aside $2 million for ongoing FCPA probe
SciClone Pharmaceuticals Inc. said it has reserved $2 million for penalties related to an ongoing Foreign Corrupt Practices Act probe.
The California-based phrama said in its annual report last week that a settlement of that size was “probable.”… Continue Reading